(2017) investigated the protective impact of erythropoietin and sildenafil against reperfusion injuries in laboratory rats with corrected testicular torsion. The authors believed erythropoietin could benefit those at risk of a reperfusion injury from corrected testicular torsion by erythropoietin’s impact on erythrocyte survival by reducing apoptosis. Sildenafil is a vasoactive medication that has been shown to significantly reduce reperfusion injury to other bodily tissues in other animal studies. The study confirmed that both erythropoietin and sildenafil have protective properties in testicular tissue against reperfusion injuries by extending the life of an erythrocyte and by reducing cellular injury (Kostakis et al., 2017). Therefore, sildenafil and erythropoietin may be viable options in the future for those at risk of a reperfusion injury secondary to corrected testicular
(2017) investigated the protective impact of erythropoietin and sildenafil against reperfusion injuries in laboratory rats with corrected testicular torsion. The authors believed erythropoietin could benefit those at risk of a reperfusion injury from corrected testicular torsion by erythropoietin’s impact on erythrocyte survival by reducing apoptosis. Sildenafil is a vasoactive medication that has been shown to significantly reduce reperfusion injury to other bodily tissues in other animal studies. The study confirmed that both erythropoietin and sildenafil have protective properties in testicular tissue against reperfusion injuries by extending the life of an erythrocyte and by reducing cellular injury (Kostakis et al., 2017). Therefore, sildenafil and erythropoietin may be viable options in the future for those at risk of a reperfusion injury secondary to corrected testicular